These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

149 related items for PubMed ID: 4604872

  • 1. Parkinson's syndrome--modern therapy, known facts and unanswered questions.
    Albert E.
    Pharmakopsychiatr Neuropsychopharmakol; 1973 Sep; 6(5):229-46. PubMed ID: 4604872
    [No Abstract] [Full Text] [Related]

  • 2. [l-dopa treatment of Parkinson's syndrome and mechanism of action of neuroleptics].
    Degkwitz R.
    Med Klin; 1969 Aug 15; 64(33):1451-6. PubMed ID: 4896563
    [No Abstract] [Full Text] [Related]

  • 3. [Biochemical bases for the treatment of Parkinson's syndrome with L-dopa].
    Pletscher A, Bartholini G, Gey KF, Jenni A.
    Schweiz Med Wochenschr; 1970 May 09; 100(19):797-804. PubMed ID: 4924275
    [No Abstract] [Full Text] [Related]

  • 4. [Etiology and therapy of Parkinson's syndrome and related pharmacological concepts shown in experimental models].
    Oehme P, Schwarz K.
    Dtsch Gesundheitsw; 1966 Apr 28; 21(17):792-8. PubMed ID: 5929188
    [No Abstract] [Full Text] [Related]

  • 5. Dopamine and extrapyramidal motor function and dysfunction.
    Hornykiewicz O.
    Res Publ Assoc Res Nerv Ment Dis; 1972 Apr 28; 50():390-415. PubMed ID: 4561070
    [No Abstract] [Full Text] [Related]

  • 6. [The drug-induced Parkinson's syndrome].
    Pakesch E.
    Wien Z Nervenheilkd Grenzgeb; 1966 Apr 28; 23(1):140-6. PubMed ID: 4226879
    [No Abstract] [Full Text] [Related]

  • 7. [Effect of dioxyphenylalanine (L-DOPA) on extrapyramidal motoric hyperkineses after prolonged neuroleptic therapy].
    Hippius H, Logemann G.
    Arzneimittelforschung; 1970 Jul 28; 20(7):894-6. PubMed ID: 5536051
    [No Abstract] [Full Text] [Related]

  • 8. [Drug-induced Parkinson's syndrome].
    Degkwitz R.
    Dtsch Med Wochenschr; 1972 Jun 02; 97(22):882. PubMed ID: 5032182
    [No Abstract] [Full Text] [Related]

  • 9. [Disturbances of catecholamine metabolism (with special reference to dopamine) in the Parkinsonian syndrome].
    Tissot R.
    Presse Med (1893); 1969 Apr 05; 77(17):617-8. PubMed ID: 5785080
    [No Abstract] [Full Text] [Related]

  • 10. [Dopaminergic conception of Parkinsonism and its treatment with L-DOPA].
    Levin SL.
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1972 Apr 05; 72(9):1418-26. PubMed ID: 4349303
    [No Abstract] [Full Text] [Related]

  • 11. [Electroconvulsive therapy in the treatment of Parkinson disease].
    Jeanneau A.
    Encephale; 1993 Apr 05; 19(5):573-8. PubMed ID: 8306926
    [Abstract] [Full Text] [Related]

  • 12. L-dopa in Parkinson's disease. A report on 95 cases and review of the literature.
    Lewis I.
    J Med Assoc State Ala; 1971 May 05; 40(11):709-18. PubMed ID: 5573008
    [No Abstract] [Full Text] [Related]

  • 13. [Study of 3-4-dihydroxyphenylacetic acid, a dopamine catabolite, in patients with Parkinson's disease before treatment with L-dopa].
    Samson M, Bohuon C, Augustin P, Comoy E, Pouliquen A.
    Rev Neurol (Paris); 1972 Aug 05; 127(2):315-7. PubMed ID: 4666641
    [No Abstract] [Full Text] [Related]

  • 14. [Persisting extrapyramidal syndrome following neuroleptic therapy].
    Nehlil J.
    Rev Neurol (Paris); 1969 Apr 05; 120(4):270-1. PubMed ID: 5343622
    [No Abstract] [Full Text] [Related]

  • 15. [Treatment of Parkinson's syndrome].
    Fortschr Med; 1982 Jun 24; 100(24):1172. PubMed ID: 7106681
    [No Abstract] [Full Text] [Related]

  • 16. [Search for the cause of Parkinson's disease].
    Langston JW.
    Arch Neurobiol (Madr); 1991 Jun 24; 54(6):264-71. PubMed ID: 1811457
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Parkinson's disease and physical therapy management.
    Wroe M, Greer M.
    Phys Ther; 1973 Aug 24; 53(8):849-55. PubMed ID: 4719852
    [No Abstract] [Full Text] [Related]

  • 19. [Current treatment of Parkinson syndrome with L-dopa].
    Gerstendbrand F, Gründig E, Musiol A.
    Pol Tyg Lek; 1972 May 22; 27(21):798-800. PubMed ID: 4555002
    [No Abstract] [Full Text] [Related]

  • 20. [Parkinson's syndrome. 1. Biochemistry of the monoamines].
    Roos BE.
    Lakartidningen; 1970 Oct 14; 67(42):4803-6. PubMed ID: 5483442
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.